FDA declines to approve nasal spray alternative to EpiPen, seeking further study, company says - ABC News
abcnews.go.comSubmitted by abcnews4704 in news
ARS Pharma shares fell sharply in pre-market trading.
Submitted by abcnews4704 in news
ARS Pharma shares fell sharply in pre-market trading.